chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blindness, Eye pain, Eye pruritus, Influenza like illness, Ocular hyperaemia
Clinical narrative: Vision loss; Gets worse daily; Eye pain; Eye inflammation; Floaters; Blurry; headache; This is a spontaneous report from a contactable consumer (reporter herself). A 28-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, batch/Lot Number: EN6206), via an unspecified route of administration, administered in arm left on 18Mar2021 11:00 (age at vaccination 28-year-old) as dose 1, single for covid-19 immunisation. Facility where COVID-19 vaccine was administered in military base. Medical history included (POTS) postural orthostatic tachycardia syndrome and factor v leiden carrier. Concomitant medications included lorazepam (ATIVAN), metoprolol tartrate and acetylsalicylic acid (ASPIRIN (E.C.)) for unspecified indication received within 2 weeks of vaccination. The patient previously took nifedipine (PROCARDIA) for allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced vision loss, gets worse daily, eye pain, eye inflammation, floaters, blurry, headache on 20Mar2021. Since the vaccination, the patient was tested for COVID-19. The patient lab test included sars-cov-2 test (nasal swab) was pending on 05Jul2021. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The treatment for the events were several doctors, ER (emergency room) visit, urgent care visits. The outcome of the events not resolved.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blindness, Condition aggravated, Eye inflammation, Eye pain, Headache
Clinical narrative: Vision loss; Gets worse daily; Eye pain; Eye inflammation; Floaters; Blurry; headache; This is a spontaneous report from a contactable consumer (reporter herself). A 28-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, batch/Lot Number: EN6206), via an unspecified route of administration, administered in arm left on 18Mar2021 11:00 (age at vaccination 28-year-old) as dose 1, single for covid-19 immunisation. Facility where COVID-19 vaccine was administered in military base. Medical history included (POTS) postural orthostatic tachycardia syndrome and factor v leiden carrier. Concomitant medications included lorazepam (ATIVAN), metoprolol tartrate and acetylsalicylic acid (ASPIRIN (E.C.)) for unspecified indication received within 2 weeks of vaccination. The patient previously took nifedipine (PROCARDIA) for allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced vision loss, gets worse daily, eye pain, eye inflammation, floaters, blurry, headache on 20Mar2021. Since the vaccination, the patient was tested for COVID-19. The patient lab test included sars-cov-2 test (nasal swab) was pending on 05Jul2021. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The treatment for the events were several doctors, ER (emergency room) visit, urgent care visits. The outcome of the events not resolved.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test, Vision blurred, Vitreous floaters
Clinical narrative: Vision loss; Gets worse daily; Eye pain; Eye inflammation; Floaters; Blurry; headache; This is a spontaneous report from a contactable consumer (reporter herself). A 28-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, batch/Lot Number: EN6206), via an unspecified route of administration, administered in arm left on 18Mar2021 11:00 (age at vaccination 28-year-old) as dose 1, single for covid-19 immunisation. Facility where COVID-19 vaccine was administered in military base. Medical history included (POTS) postural orthostatic tachycardia syndrome and factor v leiden carrier. Concomitant medications included lorazepam (ATIVAN), metoprolol tartrate and acetylsalicylic acid (ASPIRIN (E.C.)) for unspecified indication received within 2 weeks of vaccination. The patient previously took nifedipine (PROCARDIA) for allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced vision loss, gets worse daily, eye pain, eye inflammation, floaters, blurry, headache on 20Mar2021. Since the vaccination, the patient was tested for COVID-19. The patient lab test included sars-cov-2 test (nasal swab) was pending on 05Jul2021. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The treatment for the events were several doctors, ER (emergency room) visit, urgent care visits. The outcome of the events not resolved.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Erythema, Hypoaesthesia, Lip swelling, Paraesthesia
Clinical narrative: Swelling of face, lips & tongue.; Swelling of face, lips & tongue.; Swelling of face, lips & tongue.; Redness & intense burning of face, neck & chest; burning of face, neck & chest; Chest os tight; Watery & dry eyes; Watery & dry eyes; Abdominal pain on & off; Joint pain first few days.; Sore throat; This is a spontaneous report received from a contactable consumer (patient). A 41-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: unknown), via an unspecified route of administration, administered in left arm on 05Apr2021 at 03:15 PM (vaccinated at the age of 41 years) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included endometriosis from an unknown date and unknown if ongoing. Allergies to medications, food, or other products includes Levaquin, latex & shellfish. The patient was received Estradiol within 2 weeks of vaccination, taken for an unspecified indication, start and stop date were not reported. The patient was not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Apr2021 at 04:00 PM, the patient was experienced swelling of face, lips & tongue. Redness & intense burning of face, neck & chest (since date of vaccine-5 days so far). Chest os tight. Abdominal pain on & off. Watery & dry eyes. Joint pain first few days. Sore throat. The adverse event result doctor or other healthcare professional office/clinic visit. Treatment received for the adverse event with Saw pcp. The patient was not diagnosed with COVID-19, prior to vaccination and since the vaccination, the patient was not tested for COVID-19. Outcome of the events was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia oral, Swelling face, Swollen tongue
Clinical narrative: Swelling of face, lips & tongue.; Swelling of face, lips & tongue.; Swelling of face, lips & tongue.; Redness & intense burning of face, neck & chest; burning of face, neck & chest; Chest os tight; Watery & dry eyes; Watery & dry eyes; Abdominal pain on & off; Joint pain first few days.; Sore throat; This is a spontaneous report received from a contactable consumer (patient). A 41-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: unknown), via an unspecified route of administration, administered in left arm on 05Apr2021 at 03:15 PM (vaccinated at the age of 41 years) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included endometriosis from an unknown date and unknown if ongoing. Allergies to medications, food, or other products includes Levaquin, latex & shellfish. The patient was received Estradiol within 2 weeks of vaccination, taken for an unspecified indication, start and stop date were not reported. The patient was not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Apr2021 at 04:00 PM, the patient was experienced swelling of face, lips & tongue. Redness & intense burning of face, neck & chest (since date of vaccine-5 days so far). Chest os tight. Abdominal pain on & off. Watery & dry eyes. Joint pain first few days. Sore throat. The adverse event result doctor or other healthcare professional office/clinic visit. Treatment received for the adverse event with Saw pcp. The patient was not diagnosed with COVID-19, prior to vaccination and since the vaccination, the patient was not tested for COVID-19. Outcome of the events was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Arthralgia, Burning sensation, Chest discomfort, Dry eye
Clinical narrative: Swelling of face, lips & tongue.; Swelling of face, lips & tongue.; Swelling of face, lips & tongue.; Redness & intense burning of face, neck & chest; burning of face, neck & chest; Chest os tight; Watery & dry eyes; Watery & dry eyes; Abdominal pain on & off; Joint pain first few days.; Sore throat; This is a spontaneous report received from a contactable consumer (patient). A 41-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: unknown), via an unspecified route of administration, administered in left arm on 05Apr2021 at 03:15 PM (vaccinated at the age of 41 years) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included endometriosis from an unknown date and unknown if ongoing. Allergies to medications, food, or other products includes Levaquin, latex & shellfish. The patient was received Estradiol within 2 weeks of vaccination, taken for an unspecified indication, start and stop date were not reported. The patient was not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Apr2021 at 04:00 PM, the patient was experienced swelling of face, lips & tongue. Redness & intense burning of face, neck & chest (since date of vaccine-5 days so far). Chest os tight. Abdominal pain on & off. Watery & dry eyes. Joint pain first few days. Sore throat. The adverse event result doctor or other healthcare professional office/clinic visit. Treatment received for the adverse event with Saw pcp. The patient was not diagnosed with COVID-19, prior to vaccination and since the vaccination, the patient was not tested for COVID-19. Outcome of the events was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Lacrimation increased, Lip swelling, Oropharyngeal pain, Swelling face
Clinical narrative: Swelling of face, lips & tongue.; Swelling of face, lips & tongue.; Swelling of face, lips & tongue.; Redness & intense burning of face, neck & chest; burning of face, neck & chest; Chest os tight; Watery & dry eyes; Watery & dry eyes; Abdominal pain on & off; Joint pain first few days.; Sore throat; This is a spontaneous report received from a contactable consumer (patient). A 41-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: unknown), via an unspecified route of administration, administered in left arm on 05Apr2021 at 03:15 PM (vaccinated at the age of 41 years) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included endometriosis from an unknown date and unknown if ongoing. Allergies to medications, food, or other products includes Levaquin, latex & shellfish. The patient was received Estradiol within 2 weeks of vaccination, taken for an unspecified indication, start and stop date were not reported. The patient was not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Apr2021 at 04:00 PM, the patient was experienced swelling of face, lips & tongue. Redness & intense burning of face, neck & chest (since date of vaccine-5 days so far). Chest os tight. Abdominal pain on & off. Watery & dry eyes. Joint pain first few days. Sore throat. The adverse event result doctor or other healthcare professional office/clinic visit. Treatment received for the adverse event with Saw pcp. The patient was not diagnosed with COVID-19, prior to vaccination and since the vaccination, the patient was not tested for COVID-19. Outcome of the events was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swollen tongue
Clinical narrative: Swelling of face, lips & tongue.; Swelling of face, lips & tongue.; Swelling of face, lips & tongue.; Redness & intense burning of face, neck & chest; burning of face, neck & chest; Chest os tight; Watery & dry eyes; Watery & dry eyes; Abdominal pain on & off; Joint pain first few days.; Sore throat; This is a spontaneous report received from a contactable consumer (patient). A 41-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: unknown), via an unspecified route of administration, administered in left arm on 05Apr2021 at 03:15 PM (vaccinated at the age of 41 years) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included endometriosis from an unknown date and unknown if ongoing. Allergies to medications, food, or other products includes Levaquin, latex & shellfish. The patient was received Estradiol within 2 weeks of vaccination, taken for an unspecified indication, start and stop date were not reported. The patient was not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Apr2021 at 04:00 PM, the patient was experienced swelling of face, lips & tongue. Redness & intense burning of face, neck & chest (since date of vaccine-5 days so far). Chest os tight. Abdominal pain on & off. Watery & dry eyes. Joint pain first few days. Sore throat. The adverse event result doctor or other healthcare professional office/clinic visit. Treatment received for the adverse event with Saw pcp. The patient was not diagnosed with COVID-19, prior to vaccination and since the vaccination, the patient was not tested for COVID-19. Outcome of the events was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Parosmia, Vertigo, Vomiting
Clinical narrative: Vertigo; Vomiting; Dull headache; foul smell (like sulphur); This is a spontaneous report received from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via unspecified route of administration in the right arm on 17Mar2021 at 13:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. No medical history was reported. The patient had allergies to penicillin. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. On 18Mar2021 at 16:00, the patient experienced foul smell (like sulphur). After the day 6 on 24Mar2021, the patient experienced severe vertigo, vomiting and dull headache. On 24Mar2021, the patient underwent nasal swab (PCR COVID test) test and the result was negative. Unspecified treatment for vomiting and vertigo was taken. The adverse events resulted in doctor or other healthcare professional office or clinic visit. The clinical outcome of the event foul smell (like sulphur) was recovered on 21Mar2021. The clinical outcome of the events severe vertigo, vomiting and dull headache were not recovered at the time of this report.   No follow-up attempts possible. No further information expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Parosmia, SARS-CoV-2 test, Vertigo, Vomiting
Clinical narrative: Vertigo; Vomiting; Dull headache; foul smell (like sulphur); This is a spontaneous report received from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via unspecified route of administration in the right arm on 17Mar2021 at 13:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. No medical history was reported. The patient had allergies to penicillin. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. On 18Mar2021 at 16:00, the patient experienced foul smell (like sulphur). After the day 6 on 24Mar2021, the patient experienced severe vertigo, vomiting and dull headache. On 24Mar2021, the patient underwent nasal swab (PCR COVID test) test and the result was negative. Unspecified treatment for vomiting and vertigo was taken. The adverse events resulted in doctor or other healthcare professional office or clinic visit. The clinical outcome of the event foul smell (like sulphur) was recovered on 21Mar2021. The clinical outcome of the events severe vertigo, vomiting and dull headache were not recovered at the time of this report.   No follow-up attempts possible. No further information expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cheilitis, Paraesthesia oral
Clinical narrative: hives; This is a spontaneous report from a contactable consumer or other non health care professional (patient). A 68-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6201, Expiration date not reported), via an unspecified route of administration in left arm on 20Feb2021 at 14:15 (at the age of 68-year-old) as single dose for COVID-19 immunisation in School or Clinic. Medical history included chronic pain from an unknown date and unknown if ongoing. The patient had known allergies to berries, cashews, almonds, coconut, latex. The patient received other concomitant medications within two weeks included baclofen (MANUFACTURER UNKNOWN), pravastatin (MANUFACTURER UNKNOWN), montelukast sodium (SINGULAIR), budesonide (NASOCORT) for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9263, Expiration date not reported), via an unspecified route of administration in left arm on 28Jan2021 (at the age of 68-year-old) as single dose for COVID-19 immunisation and experienced within one hour after first shot, developed hives which have not gone away as of 01Jul21. Her mouth and nose burn, and she have had reactions to food/drink that she ingested. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. On 20Feb2021, at 14:25 within 10 mins after second shot, patient experienced hives really reacted. The patient received treatment due to hives with antihistamines and prednisone. The event was reported as non-serious. The outcome of event was not resolved.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: hives; This is a spontaneous report from a contactable consumer or other non health care professional (patient). A 68-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6201, Expiration date not reported), via an unspecified route of administration in left arm on 20Feb2021 at 14:15 (at the age of 68-year-old) as single dose for COVID-19 immunisation in School or Clinic. Medical history included chronic pain from an unknown date and unknown if ongoing. The patient had known allergies to berries, cashews, almonds, coconut, latex. The patient received other concomitant medications within two weeks included baclofen (MANUFACTURER UNKNOWN), pravastatin (MANUFACTURER UNKNOWN), montelukast sodium (SINGULAIR), budesonide (NASOCORT) for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9263, Expiration date not reported), via an unspecified route of administration in left arm on 28Jan2021 (at the age of 68-year-old) as single dose for COVID-19 immunisation and experienced within one hour after first shot, developed hives which have not gone away as of 01Jul21. Her mouth and nose burn, and she have had reactions to food/drink that she ingested. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. On 20Feb2021, at 14:25 within 10 mins after second shot, patient experienced hives really reacted. The patient received treatment due to hives with antihistamines and prednisone. The event was reported as non-serious. The outcome of event was not resolved.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Condition aggravated, Psoriasis, Rash, Skin lesion, Vaccine positive rechallenge
Clinical narrative: Rash on face; Red patch on neck and both arms; Burning and itching on face; Multiple red patches on neck and both arms - red and itching; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: UNKNOWN) in the left arm on 15Feb2021 at 10: 45 (at the age 0f 71-years-old) as a single dose for COVID-19 immunisation. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: UNKNOWN) in the left arm on 08Mar2021 at 10:15 (at the age 0f 71-years-old) as single dose for COVID-19 immunisation. The patient's medical history included psoriasis (mild - skin) and not psoriatic arthritis. The patient had a known allergy to BACTRIM (sulf drugs). The patient did not receive any concomitant medications. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to vaccination the patient was not diagnosed with COVID-19. Since vaccination, the patient had not tested for COVID-19.  On 24Feb2021, the patient experienced rash with swelling, burning and itching on face and multiple red patches on neck and both arms which was red and itching. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures taken as a result of rash with swelling on face, burning and itching on face, red patch on neck and both arms, red patches itching included prednisone tablets (MANUFACTURER UNKNOWN) and cortisone ointment (MANUFACTURER UNKNOWN). The clinical outcome of the events rash with swelling on face, burning and itching on face, red patch on neck and both arms, red patches itching was recovering.   No follow-up attempts are needed; information about lot/ batch number cannot be obtained.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pruritus, Rash, Rash pruritic
Clinical narrative: Rash on face; Red patch on neck and both arms; Burning and itching on face; Multiple red patches on neck and both arms - red and itching; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: UNKNOWN) in the left arm on 15Feb2021 at 10: 45 (at the age 0f 71-years-old) as a single dose for COVID-19 immunisation. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: UNKNOWN) in the left arm on 08Mar2021 at 10:15 (at the age 0f 71-years-old) as single dose for COVID-19 immunisation. The patient's medical history included psoriasis (mild - skin) and not psoriatic arthritis. The patient had a known allergy to BACTRIM (sulf drugs). The patient did not receive any concomitant medications. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to vaccination the patient was not diagnosed with COVID-19. Since vaccination, the patient had not tested for COVID-19.  On 24Feb2021, the patient experienced rash with swelling, burning and itching on face and multiple red patches on neck and both arms which was red and itching. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures taken as a result of rash with swelling on face, burning and itching on face, red patch on neck and both arms, red patches itching included prednisone tablets (MANUFACTURER UNKNOWN) and cortisone ointment (MANUFACTURER UNKNOWN). The clinical outcome of the events rash with swelling on face, burning and itching on face, red patch on neck and both arms, red patches itching was recovering.   No follow-up attempts are needed; information about lot/ batch number cannot be obtained.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Arterial thrombosis, Cardiac operation, Chest pain, Decreased appetite, Dyspnoea
Clinical narrative: hard time breathing; heart attack; minor chest pain which he thought was indigestion and heart burn; had clot arteries based in blood clots; 1 artery was 99% blocked; cold sweats; afraid to eat because he was so bloated/acid reflux; could not hold food down; out of energy; fatigued, totally out of energy; minor chest pain which he thought was indigestion and heart burn; This is a spontaneous report form a contactable consumer (patient).  A 56-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE ) on 30Mar2021 for covid-19 immunisation at the age of 56-year-old. Lot number was EP7533. Medical history included diabetes in 2018. Concomitant medications were unknown. Patient received first dose of BNT162B2 on 09Mar2021 for covid-19 immunisation (Lot Number: EN6198 Anatomical Location: Left Arm). On unknown date, electrocardiogram showed shows heart attack. The patient experienced heart attack on 06Apr2021 (treated with surgery, and received 2 stents in his heart), hard time breathing on 11Apr2021, minor chest pain on 02Apr2021 which he thought was indigestion and heart burn on 06Apr2021, had clot arteries based in blood clots, 1 artery was 99% blocked, cold sweats, fatigued and totally out of energy on 06Apr2021, afraid to eat because he was so bloated/acid reflux, vomit on 06Apr2021. The patient was hospitalized for myocardial infarction, dyspnea and chest pain. The outcome of the events was unknown. Follow up attempts are needed. Further information has been requested.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Fatigue, Myocardial infarction, Pain in extremity
Clinical narrative: hard time breathing; heart attack; minor chest pain which he thought was indigestion and heart burn; had clot arteries based in blood clots; 1 artery was 99% blocked; cold sweats; afraid to eat because he was so bloated/acid reflux; could not hold food down; out of energy; fatigued, totally out of energy; minor chest pain which he thought was indigestion and heart burn; This is a spontaneous report form a contactable consumer (patient).  A 56-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE ) on 30Mar2021 for covid-19 immunisation at the age of 56-year-old. Lot number was EP7533. Medical history included diabetes in 2018. Concomitant medications were unknown. Patient received first dose of BNT162B2 on 09Mar2021 for covid-19 immunisation (Lot Number: EN6198 Anatomical Location: Left Arm). On unknown date, electrocardiogram showed shows heart attack. The patient experienced heart attack on 06Apr2021 (treated with surgery, and received 2 stents in his heart), hard time breathing on 11Apr2021, minor chest pain on 02Apr2021 which he thought was indigestion and heart burn on 06Apr2021, had clot arteries based in blood clots, 1 artery was 99% blocked, cold sweats, fatigued and totally out of energy on 06Apr2021, afraid to eat because he was so bloated/acid reflux, vomit on 06Apr2021. The patient was hospitalized for myocardial infarction, dyspnea and chest pain. The outcome of the events was unknown. Follow up attempts are needed. Further information has been requested.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Carotid artery stent insertion, Catheterisation cardiac abnormal, Chest pain, Coronary artery disease, Myocardial infarction
Clinical narrative: hard time breathing; heart attack; minor chest pain which he thought was indigestion and heart burn; had clot arteries based in blood clots; 1 artery was 99% blocked; cold sweats; afraid to eat because he was so bloated/acid reflux; could not hold food down; out of energy; fatigued, totally out of energy; minor chest pain which he thought was indigestion and heart burn; This is a spontaneous report form a contactable consumer (patient).  A 56-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE ) on 30Mar2021 for covid-19 immunisation at the age of 56-year-old. Lot number was EP7533. Medical history included diabetes in 2018. Concomitant medications were unknown. Patient received first dose of BNT162B2 on 09Mar2021 for covid-19 immunisation (Lot Number: EN6198 Anatomical Location: Left Arm). On unknown date, electrocardiogram showed shows heart attack. The patient experienced heart attack on 06Apr2021 (treated with surgery, and received 2 stents in his heart), hard time breathing on 11Apr2021, minor chest pain on 02Apr2021 which he thought was indigestion and heart burn on 06Apr2021, had clot arteries based in blood clots, 1 artery was 99% blocked, cold sweats, fatigued and totally out of energy on 06Apr2021, afraid to eat because he was so bloated/acid reflux, vomit on 06Apr2021. The patient was hospitalized for myocardial infarction, dyspnea and chest pain. The outcome of the events was unknown. Follow up attempts are needed. Further information has been requested.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Arterial occlusive disease, Asthenia, Chest pain, Cold sweat, Dyspepsia
Clinical narrative: hard time breathing; heart attack; minor chest pain which he thought was indigestion and heart burn; had clot arteries based in blood clots; 1 artery was 99% blocked; cold sweats; afraid to eat because he was so bloated/acid reflux; could not hold food down; out of energy; fatigued, totally out of energy; minor chest pain which he thought was indigestion and heart burn; This is a spontaneous report form a contactable consumer (patient).  A 56-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE ) on 30Mar2021 for covid-19 immunisation at the age of 56-year-old. Lot number was EP7533. Medical history included diabetes in 2018. Concomitant medications were unknown. Patient received first dose of BNT162B2 on 09Mar2021 for covid-19 immunisation (Lot Number: EN6198 Anatomical Location: Left Arm). On unknown date, electrocardiogram showed shows heart attack. The patient experienced heart attack on 06Apr2021 (treated with surgery, and received 2 stents in his heart), hard time breathing on 11Apr2021, minor chest pain on 02Apr2021 which he thought was indigestion and heart burn on 06Apr2021, had clot arteries based in blood clots, 1 artery was 99% blocked, cold sweats, fatigued and totally out of energy on 06Apr2021, afraid to eat because he was so bloated/acid reflux, vomit on 06Apr2021. The patient was hospitalized for myocardial infarction, dyspnea and chest pain. The outcome of the events was unknown. Follow up attempts are needed. Further information has been requested.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Electrocardiogram, Fatigue, Gastrooesophageal reflux disease, Myocardial infarction
Clinical narrative: hard time breathing; heart attack; minor chest pain which he thought was indigestion and heart burn; had clot arteries based in blood clots; 1 artery was 99% blocked; cold sweats; afraid to eat because he was so bloated/acid reflux; could not hold food down; out of energy; fatigued, totally out of energy; minor chest pain which he thought was indigestion and heart burn; This is a spontaneous report form a contactable consumer (patient).  A 56-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE ) on 30Mar2021 for covid-19 immunisation at the age of 56-year-old. Lot number was EP7533. Medical history included diabetes in 2018. Concomitant medications were unknown. Patient received first dose of BNT162B2 on 09Mar2021 for covid-19 immunisation (Lot Number: EN6198 Anatomical Location: Left Arm). On unknown date, electrocardiogram showed shows heart attack. The patient experienced heart attack on 06Apr2021 (treated with surgery, and received 2 stents in his heart), hard time breathing on 11Apr2021, minor chest pain on 02Apr2021 which he thought was indigestion and heart burn on 06Apr2021, had clot arteries based in blood clots, 1 artery was 99% blocked, cold sweats, fatigued and totally out of energy on 06Apr2021, afraid to eat because he was so bloated/acid reflux, vomit on 06Apr2021. The patient was hospitalized for myocardial infarction, dyspnea and chest pain. The outcome of the events was unknown. Follow up attempts are needed. Further information has been requested.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Thrombosis, Vomiting
Clinical narrative: hard time breathing; heart attack; minor chest pain which he thought was indigestion and heart burn; had clot arteries based in blood clots; 1 artery was 99% blocked; cold sweats; afraid to eat because he was so bloated/acid reflux; could not hold food down; out of energy; fatigued, totally out of energy; minor chest pain which he thought was indigestion and heart burn; This is a spontaneous report form a contactable consumer (patient).  A 56-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE ) on 30Mar2021 for covid-19 immunisation at the age of 56-year-old. Lot number was EP7533. Medical history included diabetes in 2018. Concomitant medications were unknown. Patient received first dose of BNT162B2 on 09Mar2021 for covid-19 immunisation (Lot Number: EN6198 Anatomical Location: Left Arm). On unknown date, electrocardiogram showed shows heart attack. The patient experienced heart attack on 06Apr2021 (treated with surgery, and received 2 stents in his heart), hard time breathing on 11Apr2021, minor chest pain on 02Apr2021 which he thought was indigestion and heart burn on 06Apr2021, had clot arteries based in blood clots, 1 artery was 99% blocked, cold sweats, fatigued and totally out of energy on 06Apr2021, afraid to eat because he was so bloated/acid reflux, vomit on 06Apr2021. The patient was hospitalized for myocardial infarction, dyspnea and chest pain. The outcome of the events was unknown. Follow up attempts are needed. Further information has been requested.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Flushing, Injection site pain, Pain in jaw, Pain of skin, Palpitations
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 17Mar2021 at 12:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccine within 4 weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 17Mar2021 at 12:00, the patient was 9 days out and had a lot of shortness of breath, jaw pain, fatigue, night sweats and generally feeling not well. This was after a single dose and never had COVID. It was unknown if the patient received any treatment for the reported events. The adverse events resulted in emergency room/department or urgent care visit. The outcome of the events lot of shortness of breath, jaw pain, fatigue, night sweats and generally feeling not well were not resolved at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Fatigue, Malaise, Night sweats, Pain in jaw
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 17Mar2021 at 12:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccine within 4 weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 17Mar2021 at 12:00, the patient was 9 days out and had a lot of shortness of breath, jaw pain, fatigue, night sweats and generally feeling not well. This was after a single dose and never had COVID. It was unknown if the patient received any treatment for the reported events. The adverse events resulted in emergency room/department or urgent care visit. The outcome of the events lot of shortness of breath, jaw pain, fatigue, night sweats and generally feeling not well were not resolved at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphonia, Productive cough, Throat irritation
Clinical narrative: she had anaphylactic shock; she was not able to complete the vaccination series; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 28Feb2021 as first dose, single for COVID-19 immunization. Medical history included breast cancer and radiation therapy. The patient's concomitant medications were not reported. On 28Feb2201, 45 minutes later, the patient experienced anaphylactic shock. She went to 5 doctors and all of them did not recommend her to get the 2nd dose. She had the antibody test (164060-SARS - COV 2 antibody IgG) and tested negative. It was reported that she was not able to complete the vaccination series, her doctor advised her to have antibody testing to show that she still developed immunity from the 1st dose. She will travel internationally and she might need to have some proof of vaccination handy. She asked what would be her recourse and if Pfizer could give any recommendations on her situation. The patient underwent lab tests and procedures which included antibody test: negative on an unspecified date in 2021. Seriousness of anaphylactic shock was medically significant. The clinical outcome of the events was unknown.  Information about batch/Lot number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic shock, Antibody test, Incomplete course of vaccination
Clinical narrative: she had anaphylactic shock; she was not able to complete the vaccination series; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 28Feb2021 as first dose, single for COVID-19 immunization. Medical history included breast cancer and radiation therapy. The patient's concomitant medications were not reported. On 28Feb2201, 45 minutes later, the patient experienced anaphylactic shock. She went to 5 doctors and all of them did not recommend her to get the 2nd dose. She had the antibody test (164060-SARS - COV 2 antibody IgG) and tested negative. It was reported that she was not able to complete the vaccination series, her doctor advised her to have antibody testing to show that she still developed immunity from the 1st dose. She will travel internationally and she might need to have some proof of vaccination handy. She asked what would be her recourse and if Pfizer could give any recommendations on her situation. The patient underwent lab tests and procedures which included antibody test: negative on an unspecified date in 2021. Seriousness of anaphylactic shock was medically significant. The clinical outcome of the events was unknown.  Information about batch/Lot number has been requested.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Food allergy, Oral discomfort, Paraesthesia oral, Urticaria
Clinical narrative: My mouth and nose burn, and Ive had reactions to food/drink that Ive ingested all my life.; Within one hour after first shot, I developed hives which have NOT gone away as of 01Jul2021; This is a spontaneous report from a contactable consumer, the patient. A 68-years-old non pregnant female patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EL9263) via an unspecified route of administration, administered in Arm Left on 28Jan2021 (at the age of 68 years old) as DOSE 1, SINGLE for covid-19 immunization. Medical history included chronic pain, food allergy (berries, cashews, almonds, coconut, latex) and rubber sensitivity from an unknown date and unknown if ongoing. Concomitant medications included baclofen, pravastatin, montelukast sodium (SINGULAIR) and Nasacort taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Within one hour after first shot on 28Jan2021, patient developed hives which have not gone away as of 01Jul2021. On 28Jan2021 at 19:00, the patient experienced mouth and nose burn, and had reactions to food/drink that patient had ingested all the life. Therapeutic measures were taken as a result of the events. Patient took antihistamines and Prednisone as treatment for all events. The outcome of the events was not recovered.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Burning sensation, Urticaria
Clinical narrative: My mouth and nose burn, and Ive had reactions to food/drink that Ive ingested all my life.; Within one hour after first shot, I developed hives which have NOT gone away as of 01Jul2021; This is a spontaneous report from a contactable consumer, the patient. A 68-years-old non pregnant female patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EL9263) via an unspecified route of administration, administered in Arm Left on 28Jan2021 (at the age of 68 years old) as DOSE 1, SINGLE for covid-19 immunization. Medical history included chronic pain, food allergy (berries, cashews, almonds, coconut, latex) and rubber sensitivity from an unknown date and unknown if ongoing. Concomitant medications included baclofen, pravastatin, montelukast sodium (SINGULAIR) and Nasacort taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Within one hour after first shot on 28Jan2021, patient developed hives which have not gone away as of 01Jul2021. On 28Jan2021 at 19:00, the patient experienced mouth and nose burn, and had reactions to food/drink that patient had ingested all the life. Therapeutic measures were taken as a result of the events. Patient took antihistamines and Prednisone as treatment for all events. The outcome of the events was not recovered.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Chest X-ray normal, Computerised tomogram normal, Electrocardiogram normal, Electroencephalogram normal
Clinical narrative: Had a seizure; This is a spontaneous report from a contactable consumer (patient self).  A 75-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) Solution for injection, via an unspecified route of administration, administered in Arm Right on 19Apr2021 11:00 (Lot Number: EW0170) as dose 1, single (at the age of 75-year-old) for COVID-19 immunisation.  Medical history included ongoing controlled high blood pressure. Concomitant medications included amlodipine; hctz; simvastatin.  Prior to vaccination, the patient did not diagnose with COVID-19.  There was no other vaccine in four weeks. Facility type vaccine: Pharmacy or Drug store.  The patient had a seizure on 23Apr2021 19:30 which resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization for 1 day in 2021.  The patient underwent lab tests and procedures which included Covid Blood test of Antibody post vaccination: positive on 11Jun2021, Covid 19 test post vaccination: negative on 23Apr2021. No treatment received. Outcome of the event was resolved in 2021.  Follow-Up (30Jun2021): Follow-up attempts are completed. No further information is expected.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Laboratory test normal, Magnetic resonance imaging normal, Seizure, Ultrasound Doppler normal
Clinical narrative: Had a seizure; This is a spontaneous report from a contactable consumer (patient self).  A 75-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) Solution for injection, via an unspecified route of administration, administered in Arm Right on 19Apr2021 11:00 (Lot Number: EW0170) as dose 1, single (at the age of 75-year-old) for COVID-19 immunisation.  Medical history included ongoing controlled high blood pressure. Concomitant medications included amlodipine; hctz; simvastatin.  Prior to vaccination, the patient did not diagnose with COVID-19.  There was no other vaccine in four weeks. Facility type vaccine: Pharmacy or Drug store.  The patient had a seizure on 23Apr2021 19:30 which resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization for 1 day in 2021.  The patient underwent lab tests and procedures which included Covid Blood test of Antibody post vaccination: positive on 11Jun2021, Covid 19 test post vaccination: negative on 23Apr2021. No treatment received. Outcome of the event was resolved in 2021.  Follow-Up (30Jun2021): Follow-up attempts are completed. No further information is expected.